Toledano Miranda Jayne, CEO of Entera Bio Ltd. ($ENTXW), made one open market purchase of shares in the last year, totaling $19,912. Her most recent buy was on December 29, 2025. This ranks her 3,855th out of 4,983 insiders by purchase value, well below the average of $1.5 million across 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2025 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | P | Ordinary Shares, par value NIS 0.0000769 per share | 11000 | $1.81 | 426,575.0000 | 47,089,814 | 2.65% | 0.02% |
| Aug. 5, 2025 | Journey Medical Corp | $DERM | Toledano Miranda Jayne | Director | A | Common Stock, $0.0001 par value | 20000 | $0.00 | 108,618.0000 | 23,290,806 | 22.57% | 0.09% |
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 136842 | $0.00 | 371,715.0000 | 37,650,179 | 58.26% | 0.36% |
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 43860 | $0.00 | 415,575.0000 | 37,650,179 | 11.80% | 0.12% |
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 37,650,179 | 9999.99% | 1.33% |
| June 25, 2025 | Journey Medical Corp | $DERM | Toledano Miranda Jayne | Director | A | Common Stock, $0.0001 par value | 7173 | $0.00 | 88,618.0000 | 22,611,040 | 8.81% | 0.03% |
| July 31, 2024 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 29,007,794 | 9999.99% | 1.72% |
| July 31, 2024 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 124121 | $0.00 | 234,873.0000 | 29,007,794 | 112.07% | 0.43% |
| July 8, 2024 | Journey Medical Corp | $DERM | Toledano Miranda Jayne | Director | A | Common Stock, $0.0001 par value | 9728 | $0.00 | 81,445.0000 | 19,993,858 | 13.56% | 0.05% |
| Dec. 22, 2023 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | P | Ordinary Shares, par value NIS 0.0000769 per share | 23952 | $0.71 | 110,752.0000 | 0 | 27.59% | 0.00% |
| Dec. 22, 2023 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | P | Warrants (right to buy) | 23952 | $0.13 | 23,952.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2023 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2023 | Entera Bio Ltd. | $ENTX | Toledano Miranda Jayne | Chief Executive Officer | P | Ordinary Shares, par value NIS 0.0000769 per share | 30000 | $1.01 | 86,800.0000 | 0 | 52.82% | 0.00% |